Leadership
Tonix is led by an executive team with significant industry experience in drug development. The expertise and relationships of our passionate leadership team make Tonix Pharmaceuticals’ mission possible through proprietary developments and strategic collaborations with world-class academic and non-profit research organizations.
Executive Team
Seth Lederman, MD
Co-Founder, CEO & Chairman
Bradley Saenger, CPA
Chief Financial Officer
Jessica Morris
Chief Operating Officer
Siobhan Fogarty, BSc, MSc(QP)
Chief Technical Officer
Thomas Englese, MBA
Chief Commercial Officer
George Lederman, PhD
Executive Vice President, Strategy and Transformation
Sina Bavari, PhD
Executive Vice President, Infectious Disease Research and Development
Bruce Daugherty, PhD, MBA
Executive Vice President, Research
Darryl Rideout, PhD
Executive Vice President, Experimental Chemistry
Zeil Rosenberg, MD, MPH
Executive Vice President, Medical
Irina Ishak, JD
General Counsel
Seth Lederman, MD
Co-Founder, CEO & Chairman
Bradley Saenger, CPA
Chief Financial Officer
Jessica Morris
Chief Operating Officer
Siobhan Fogarty, BSc, MSc(QP)
Chief Technical Officer
Thomas Englese, MBA
Chief Commercial Officer
George Lederman, PhD
Executive Vice President, Strategy and Transformation
Sina Bavari, PhD
Executive Vice President, Infectious Disease Research and Development
Bruce Daugherty, PhD, MBA
Executive Vice President, Research
Darryl Rideout, PhD
Executive Vice President, Experimental Chemistry
Board of Directors
Seth Lederman, MD
Co-Founder, CEO & Chairman
Richard H. Bagger
Director
Margaret Smith Bell
Director
Major General David Grange (ret)
Director
Adeoye Olukotun, MD
Director
R. Newcomb Stillwell, JD
Director
Carolyn E. Taylor
Director
James Treco
Director